David Veitch
Chief Executive Officer presso BASILEA PHARMACEUTICA AG
Patrimonio netto: 54 341 $ in data 31/03/2024
Profilo
David Veitch is currently the Chief Executive Officer at Basilea Pharmaceutica AG since 2018.
Prior to this, he was the President-European Operations at Savient Pharmaceuticals, Inc. from 2012 to 2013.
He also served as the SVP-European Marketing & Brand Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd.
from 2007 to 2011.
Mr. Veitch completed his undergraduate degree at the University of Bristol.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BASILEA PHARMACEUTICA AG
0.01% | 31/12/2022 | 1 300 ( 0.01% ) | 54 341 $ | 31/03/2024 |
Posizioni attive di David Veitch
| Società | Posizione | Inizio |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Chief Executive Officer | 19/04/2018 |
Precedenti posizioni note di David Veitch
| Società | Posizione | Fine |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2013 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 01/01/2011 |
Formazione di David Veitch
| University of Bristol | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BASILEA PHARMACEUTICA AG | Health Technology |
| Aziende private | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
- Borsa valori
- Insiders
- David Veitch
